The treatment could change millions of lives.
, which enables better management of blood sugar levels – and also aids weight loss.
Over two years, the team followed 10 patients who had been diagnosed with type 1 diabetes within the previous three to six months. Their average blood sugar level, or HbA1c, was 11.7, far above the American Diabetes Association’s HbA1c recommendation of 7 or below.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Weight loss 'miracle' drug Ozempic was inspired by monster venomIt was inspired by an actual monster.
Læs mere »
Shropshire business confidence 'brittle' amid cost-of-living fearsBusiness confidence remains brittle in Shropshire as cost-of-living concerns and recruitment troubles continue to weigh heavily on the minds of many employers.
Læs mere »
When Should Kids Walk To School Alone? Experts Weigh InHere are some things to go over with your child before they head off with their backpack.
Læs mere »
Weight loss 'miracle' drug Ozempic was inspired by monster venomIt was inspired by an actual monster.
Læs mere »
After treatment with semaglutide, newly diagnosed type 1 diabetes patients found to need little or no insulinTreating newly diagnosed type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
Læs mere »
How Wegovy helps people to lose weight and its side effectsStudies have shown that Wegovy, a brand name of semaglutide, is effective in helping people lose weight, with a significant proportion of them achieving at least a 5 per cent weight loss.
Læs mere »